Search Results - platforms+%3e+diagnostic+platform+technologies

111 Results

Sort By:

Swabseq Universal Pathogen Diagnostic Platform (Case No. 2026-121)

Summary: UCLA researchers in the Department of Computer Science have developed a next-generation universal pathogen diagnostic platform combining scalable genomic sequencing, simplified laboratory workflows, and integrated logistics infrastructure to enable rapid, low-cost, high-throughput infectious disease detection. Background: The rise of pathogen-specific...

Published: 6/5/2026 | Inventor(s): Eleazar Eskin, Valerie Arboleda, Chongyuan Luo, Taryn Jakub, Traci Toy

Keywords(s): AI-guided diagnostics, Assay, Computer-Aided Diagnosis, COVID-19, Diagnostic Markers & Platforms, diagnostic platforms, Diagnostic Test, diagnostics, Infectious Diseases, Infrastructure, Medical diagnostics, metagenomic diagnostic platform, Pathogen, platform technology, scalable platform

Category(s): Therapeutics > Infectious Diseases, Therapeutics > Infectious Diseases > COVID, Software & Algorithms > Digital Health, Software & Algorithms, Platforms > Diagnostic Platform Technologies, Platforms, Diagnostic Markers, Diagnostic Markers > Targets And Assays

Enzyme-Based Method for the Amplified Detection of Molecules on Particles (Case No. 2026-130)

Summary: UCLA researchers in the Department of Bioengineering have developed a novel enzyme-based particle platform that enables amplified molecular detection in fully aqueous systems for sensitive, multiplexed analysis of low-abundance analytes. Background: The detection of molecules and determination of enzymatic activity are foundational across...

Published: 6/5/2026 | Inventor(s): Alyssa Arnheim, Dino Di Carlo

Keywords(s): Antibody, Aptamers, Assay, barcode, Biomarker, Biosensor, Diagnostic Markers & Platforms, Diagnostic Platform Technologies (E.G. Microfluidics), Drug Discovery, ELISA, enzyme functionalization, Enzyme Substrate (Biology), Flow Cytometry, Fluorescence, High-Throughput Screening, hydrogel, Immunoassay, Medical diagnostics, microparticles, Molecular Biology, multiplexed analysis, multiplexing, Nucleic Acids, protein, Signal-To-Noise Ratio

Category(s): Diagnostic Markers > Targets And Assays, Diagnostic Markers, Platforms > Diagnostic Platform Technologies, Chemical > Chemical Sensors, Life Science Research Tools > Antibodies

Summary: A UCLA researcher in the Department of Medicine, Hematology Oncology has developed a computational framework to model subcellular orientation for spatial biology Background: Spatial biology allows researchers to map the coordinates of proteins with subcellular resolution, revolutionizing our understanding of disease. Critical cellular processes...

Published: 6/3/2026 | Inventor(s): Katie Campbell, Daniel Chen, Taejus Yee

Keywords(s):

Category(s): Diagnostic Markers, Diagnostic Markers > Immunology, Diagnostic Markers > Cancer, Platforms, Platforms > Diagnostic Platform Technologies, Software & Algorithms, Software & Algorithms > Image Processing, Software & Algorithms > Programs, Software & Algorithms > Bioinformatics, Software & Algorithms > Data Analytics, Software & Algorithms > Digital Health

A Novel Biomarker and Therapeutic Target for Atrial Fibrillation in Humans (UCLA Case No. 2024-041)

UCLA researchers at the Geffen School of Medicine have identified a novel biomarker and therapeutic target for early diagnosis and treatment of post-operative atrial fibrillation. BACKGROUND: Post-operative atrial fibrillation (POAF) is a common complication following cardiac surgery, affecting 30-50% of patients. Patients who develop POAF have an...

Published: 3/26/2026 | Inventor(s): Thomas Vondriska, Matthew Fischer

Keywords(s):

Category(s): Diagnostic Markers > Targets And Assays, Platforms > Diagnostic Platform Technologies, Therapeutics > Cardiovascular

Compositions and Methods to Modulate MAVS-Mediated Immunity (UCLA Case No. 2026-096)

UCLA researchers in the Department of Microbiology, Immunology, and Molecular Genetics have developed methods to target TOM70, a mitochondrial outer membrane protein, to selectively modulate innate immune signaling and control pathological or protective immune responses across a range of clinical conditions. BACKGROUND: Innate immune detection of viral...

Published: 2/18/2026 | Inventor(s): Lena Pernas

Keywords(s):

Category(s): Diagnostic Markers > Targets And Assays, Diagnostic Markers > Immunology, Diagnostic Markers > Cancer, Platforms > Diagnostic Platform Technologies, Therapeutics > Oncology, Therapeutics > Infectious Diseases, Therapeutics > Immunology And Immunotherapy, Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Autoimmune, Therapeutics > Vaccines

Highly Miniaturized Closed-Loop Biosensing and Drug Delivery (Case No. 2025-276)

Summary: UCLA researchers in the Department of Electrical and Computer Engineering have developed an implantable closed-loop system that integrates electrochemical biosensing, wireless signal transmission, and programmable drug release. Background: Conventional disease management systems rely on single-point measurements and discrete interval drug...

Published: 2/5/2026 | Inventor(s): Aydin Babakhani, Iman Habibagahi, Hamid Jafarisharemi, Roshan Mathews

Keywords(s): biomedical implantation, biomedical sensors, Drug Delivery, Drug monitoring, Implant (Medicine), implantable sensors, Medical Device, minimally invasive drug delivery systems, on-demand drug delivery, personalized dose assessment, Smart medical device, Therapeutics, wearable, wearable electronics, wearable medical device, wearable medical devices, wearable sensors, wearable sensors for health, Wireless, wireless communication

Category(s): Life Science Research Tools, Electrical, Medical Devices, Platforms > Diagnostic Platform Technologies, Platforms > Drug Delivery, Platforms

An Acoustic Device for Large Area Single Cell Trapping and Selective Release (Case No. 2025-047)

Summary: UCLA researchers in the Department of Mechanical and Aerospace Engineering have developed an acoustic microfluidic platform that offers a cost-effective and practical approach for handling individual cells at the microscale. Background: Single-cell manipulation is essential for understanding cellular behavior, disease progression, and therapeutic...

Published: 1/13/2026 | Inventor(s): Pei-Yu Chiou, Xiang Zhang

Keywords(s): acoustic microfluidics, acoustic potential wells, acoustics, cell proliferation, cell viability, Diagnostic Platform Technologies (E.G. Microfluidics), diagnostic platforms, Digital Microfluidics, disposable microfluidic platforms, high throughput, high throughput assays, high throughput testing, High-Content Screening, high-throughput cell handling, low-cost fabrication, MEMS, MEMS metasurface, micro-electromechanical systems (MEMS), Microfluidics, Microfluidics And Mem's, Microfluidics Dielectrophoresis, Microfluidics Multi-Band Device, Microfluidics Nanosphere, near-infrared laser, photolithography-free fabrication, research instrumentation, scalable platform, single cell analysis, single cell analysis and testing, Single cell data, single-cell handling, single-cell manipulation, single-cell resolution, single-cell trapping

Category(s): Chemical, Chemical > Chemical Processing & Manufacturing, Chemical > Instrumentation & Analysis, Diagnostic Markers, Diagnostic Markers > Targets And Assays, Diagnostic Markers > Immunology, Diagnostic Markers > Cancer, Life Science Research Tools, Life Science Research Tools > Lab Equipment, Life Science Research Tools > Microfluidics And Mems, Life Science Research Tools > Research Methods, Mechanical, Mechanical > Instrumentation, Platforms, Platforms > Diagnostic Platform Technologies

Oral-Gut-Brain Axis Virome/Microbiome for Periodontitis, Irritable Bowel Disease and Alzheimer’s Disease Diagnostics (UCLA Case No. 2024-222)

UCLA researchers in the School of Dentistry and section of Biosystems and Function have developed a novel diagnostic protocol to accurately categorize both the virome and microbiome of the oral-gut-brain axis for periodontitis, irritable bowel disease, and Alzheimer’s disease pathologies. BACKGROUND: Humans are host to a large and diverse set...

Published: 1/7/2026 | Inventor(s): Yvonne Kapila

Keywords(s):

Category(s): Diagnostic Markers > Targets And Assays, Platforms > Diagnostic Platform Technologies

Method and Apparatus for Acceleration of Dense MR Data Acquisition (Case No. 2025-226)

Summary: UCLA researchers from the Department of Radiological Sciences have developed a novel acquisition and reconstruction strategy that accelerates Displacement Encoding with Stimulated Echoes (DENSE) MRI, enabling faster and clinically feasible cardiac strain measurement. Background: Myocardial strain is an important biomarker for assessing how...

Published: 11/19/2025 | Inventor(s): Xiaodong Zhong, Shu-Fu Shih

Keywords(s):

Category(s): Electrical > Imaging, Electrical > Signal Processing, Medical Devices > Cardiac, Medical Devices > Medical Imaging, Medical Devices > Medical Imaging > MRI, Platforms > Diagnostic Platform Technologies, Software & Algorithms > Data Analytics, Software & Algorithms, Software & Algorithms > Image Processing

Use of Blood, Bronchoalveolar Lavage Fluid (BALF) or Urine Cytokines Combined With Donor-Derived Cell-Free DNA (dd-cfDNA) as a Biomarker of Allograft (UCLA Case No. 2025-316)

UCLA researchers in the Department of Pulmonology have identified a novel non-invasive combinatorial biomarker for prediction, early detection, and monitoring of acute and chronic allograft injury. BACKGROUND: Post-surgery treatment and rejection surveillance for solid organ transplantation remains challenging, primarily due to a limited ability to...

Published: 10/3/2025 | Inventor(s): Yusaku Shino

Keywords(s):

Category(s): Diagnostic Markers > Targets And Assays, Diagnostic Markers > Immunology, Platforms > Diagnostic Platform Technologies

1 2 3 4 5 6 7 8 9 10 ...